Vaxil Bio Ltd VXLLF

Primary Symbol: V.VXL

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Now we can go back to a dime ...

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Nov 16, 2021 5:58am

63 Views

Post# 34130421

RE:RE:RE:Now we can go back to a dime ...

We were trading above a dime before they announced that ridiculous Shroom dilution acquisition and now were still trying to recover ......if the market liked the announcement we would have been up with huge volume but that never happened either .....